Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Canadian-under $3.00 Stock-Picking Challenge -- Ignore unavailable to you. Want to Upgrade?

To: brian krause who wrote (1140)	3/17/2001 11:00:12 AM
From: Al Collard	Respond to of 11802

Hi Brian, Or should I say "guru" Brian? Congrats on your winning pick last week !!! Your in with KNX-v @$.20 for 50,000 shares. Chart for Knexa.com Enterprises, Inc.(KNX-v): stockcharts.com[l,a]declnimy[pb50!c20!b100!b200][vc60][iUg!Ll14!La12,26,9!Lf!Lh14,3] Lookin at the chart the one things that stands out about this stock is the extremely sold down condition of it. Thursday's dragon-fly dogi should signify a major turning point for this stock and in fact it did close up on Friday. Personally I wouldn't enter a position at this point but wait to it has a complete candle close above it's 20EMA @$.25 As always one NR and this stock could have a major reversal of fortunes. Good luck with your pick next week, Al

To: brian krause who wrote (1140)	3/22/2001 8:59:27 AM
From: Al Collard	Read Replies (1) \| Respond to of 11802

KNX-v ...News Release Mr. David Brett reports Knexa.com's IntraKnexa knowledge management solution will initially be tailored to meet the growing need for accelerated knowledge flow in the biotechnology and pharmaceutical sectors. According to Dr. Wendy Leong, DPharm, a Knexa advisory board member: "Pharmaceutical manufacturers must find ways to create and collect knowledge, cheaper, for a significantly shorter time to new drug product development and time to market. Knowledge accelerated drug development is the key to survival in this highly innovative industry." Knexa plans to engage users to test the beta version of IntraKnexa by the second quarter of 2001 and expects to generate significant revenues from IntraKnexa by the end of 2001. Knexa will modify its IntraKnexa system to meet the unique conditions facing the life sciences sector, which some KM practitioners have described as the perfect information storm. Industry observers indicate that per-drug savings of $200-million (U.S.) in cash and two to three years in development time, are achievable using new knowledge and information management systems. "Fields like genomics and proteomics are causing a massive explosion of information," said Knexa's chief executive officer, David Brett. "IntraKnexa is designed to help knowledge workers create and share new knowledge fostered by this information revolution." A recent Ipsos-Reid study shows 91 per cent of Canadian business leaders believe knowledge management practices directly impact organizational effectiveness. According to this study, "One third of organizations without KM practices in place have plans to implement one in the next 12 months." On Monday, March 26, at 4 p.m., Knexa's chief knowledge officer, Dr. Nick Bontis, will deliver a keynote address at Information Highways 2001 Conference and Product Exhibition (March 26 to March 27) at the Metro Toronto Convention Centre. The goal of this talk is to frame and advance the fields of organizational learning, intellectual capital and knowledge management, to conceptualize organizational knowledge stocks and flows, and to describe best measurement practices in the field. Dr. Bontis predicts the future state of a knowledge-rich workplace and how individuals can succeed in this workplace. For further information visit: www.informationhighways.net.